The FDA authorized the first test April 20 to identify emerging pathogen Candida auris, which can lead to serious infections in hospitalized patients. In particular, the agency approved marketing for ...
An estimated 1.5 million deaths worldwide are attributed to invasive fungal diseases annually. 5 Of these, hospital-acquired infections—most frequently caused by species of Candida—account for around ...
It’s common knowledge that eating a diet consisting of ultra-processed foods isn’t exactly great for the body. But did you know that it can actually change the bacteria makeup of your gut? Considering ...
Candida vs. Yeast Infection Because yeast infections are so common, numerous anti-Candida diets have bloomed in response. The most popular is the Candida diet, which subscribes to the notion that ...
Matching an infection with Candida auris, a pathogenic yeast, to an effective antifungal is a critical clinical decision. That decision relies on susceptibility testing, but commercially available ...
On TikTok, women are changing their diets to resolve candida overgrowth, all with varying strictness and habits, with three nutritionists explaining to Newsweek how to effectively tackle candida with ...
SILVER SPRING, Md., April 20, 2018 /PRNewswire-USNewswire/ -- Today the U.S. Food and Drug Administration authorized the first test to identify the emerging pathogen Candida auris (C. auris), which ...
If you’re constantly feeling bloated, nauseous, or tend to get recurring yeast infections, it may be a sign to try the Candida diet, a low-sugar, anti-inflammatory diet designed to improve your gut ...
If you’re constantly feeling bloated, nauseous, or tend to get recurring yeast infections, it may be a sign to try the Candida diet, a low-sugar, anti-inflammatory diet designed to improve your gut ...
LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the ...
Houston, TX – Matching an infection with Candida auris, a pathogenic yeast, to an effective antifungal is a critical clinical decision. That decision relies on susceptibility testing, but commercially ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results